for Asp C3 , which was similar (26.5 vs. 27.0 min). The slower turnover of glutamate in the nerve terminals (but not GABA) compared to the cortex may reflect selective effects of anesthesia on activity-dependent glucose use, which might be more pronounced in the terminals. The 13 C labeling ratio for glutamate-C4 from [2-13 C]acetate over that of 13 C-glucose was twice as large in nerve terminals compared to cortex, suggesting that astroglial glutamine under the 13 C glucose infusion was the likely source of much of the nerve terminal dilution. The net replenishment of most of the nerve terminal amino acid pools occurs directly via trafficking of astroglial glutamine.
Introduction
The physical and functional aspects of brain glutamate compartmentation are well-known and essential features of glutamatergic and GABAergic neurotransmission [1] [2] [3] . Glutamate plays multiple roles in CNS function. The major excitatory neurotransmitter and precursor of GABA, glutamate is also the precursor of glutamine formed in astrocytes, which is the major source of new glutamate and GABA synthesis in neurons [3, 4] . Glutamate also plays a fundamental role in glucose and mitochondrial energy metabolism in neurons and astrocytes [5] [6] [7] [8] [9] [10] [11] .
The development and application of nuclear magnetic resonance spectroscopy and mass spectrometry in conjunction with 13 C and 15 N labeled substrates have greatly advanced studies of carbon and nitrogen metabolism in cultured cells and neural tissues in vitro [12] [13] [14] [15] [16] [17] [18] and in
Abstract
The 13 C turnover of neurotransmitter amino acids (glutamate, GABA and aspartate) were determined from extracts of forebrain nerve terminals and brain homogenate, and fronto-parietal cortex from anesthetized rats undergoing timed infusions of [1,6- 13 C 2 ]glucose or [2- 13 C]acetate. Nerve terminal 13 C fractional labeling of glutamate and aspartate was lower than those in whole cortical tissue at all times measured (up to 120 min), suggesting either the presence of a constant dilution flux from an unlabeled substrate or an unlabeled (effectively noncommunicating on the measurement timescale) glutamate pool in the nerve terminals. Half times of 13 C labeling from [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose, as estimated by least squares exponential fitting to the time course data, were longer for nerve terminals (Glu C4 , 21.8 min; GABA C2 21.0 min) compared to cortical tissue (Glu C4 , 12.4 min; GABA C2 , 14.5 min), except Electronic supplementary material The online version of this article (doi:10.1007/s11064-016-2103-x) contains supplementary material, which is available to authorized users.
animal and human brain in vivo [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Analysis of dynamic time courses of 13 C enrichment using metabolic modeling has been used to compute absolute rates of specific pathways (e.g., rates of TCA cycle and neurotransmitter cycling) from analysis of 13 C amino acid turnover [23, [31] [32] [33] [34] [35] . Considerable effort has gone into validating the overall consistency of these models in terms of mass and isotope (carbon and nitrogen) balance, and the calculated fluxes as compared to independent methods [29] . Less well known, however, is the influence that intracellular compartmentation may have on the kinetics of glutamate labeling from 13 C-labeled glucose and other substrates. The energetics of glutamate and GABA neurotransmission has been studied in vivo in conjunction with 13 C labeled substrate infusion and 13 C NMR spectroscopy both in rats [24, 25, 27, 34, [36] [37] [38] [39] and in human subjects [23, 28, 40] . Results of these in vivo 13 C NMR measurements have established a near 1:1 linear relationship between neurotransmitter cycling (V cyc ) and neuronal glucose oxidation (CMR glc(ox)N ) above isoelectricity [27, 39, 41] , indicating that in neurons, the energy supporting glutamatergic neurotransmission is provided mainly by the oxidation of glucose in the tricarboxylic acid (TCA) cycle. This relationship is consistent with calculations of the energetics of specific ion flows associated with glutamatergic neurotransmission [42, 43] . Different molecular-mediated coupling mechanisms have been proposed to explain this relationship [10, [44] [45] [46] [47] [48] [49] . The in vivo 13 C NMR spectroscopic measurements of fluxes reflect whole tissue averages of large populations of neurons and astrocytes. The structure of metabolic models of neuron-astrocyte trafficking used to calculate metabolic fluxes from glutamate, GABA and glutamine 13 C turnover treats neural cells as single homogeneous compartments, with no differentiation of presynaptic terminals from postsynaptic dendrites or soma. As recent electrophysiological studies [50, 51] and a revised energy budget [52, 53] show greater energy expenditure associated with dendrites, the potential influence of subcellular compartmentation of neurons on the fluxes estimated by MRS is of substantial interest.
The compartmentation of neurotransmitter glutamate and GABA between metabolic and vesicular pools is well known [1, 2] . Nerve terminals isolated from rodents and incubated with substrates labeled in 3 H, 14 C or 13 C have revealed the complex interplay between mitochondrial, cytoplasmic and vesicular components required for neurotransmitter glutamate and GABA synthesis. These studies have characterized precursors and transporters [54] [55] [56] and enzymes expressed in nerve terminal mitochondria and cytoplasm [6, [57] [58] [59] necessary for the synthesis and release of glutamate and GABA at the synapse [60] . Nerve terminals studied in vitro, however, necessarily reflect conditions far removed from their normal cellular and extracellular physiological environment, neural inputs and astroglial interactions. Recently, we reported that nerve terminals isolated from rodents immediately after a timed intravenous infusion of 13 C-labeled glucose retain high levels of glutamate and GABA providing a measure of their in vivo enrichment at the time of euthanasia. Thus, the ability to isolate presynaptic nerve terminals, the crucial neuronal compartment of glutamate/GABA-glutamine cycling, provides an opportunity to validate and more accurately interpret metabolic fluxes determined in brain tissue in vivo using 13 C magnetic resonance spectroscopy with multicompartment metabolic modeling.
In this study, 13 C turnover of neurotransmitter glutamate and GABA was investigated in presynaptic nerve terminals isolated from the forebrain of rats infused with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose and [2-13 C]acetate and compared with the corresponding values in forebrain homogenates and cerebral cortex. We find, consistent with prior studies of cerebral cortical tissue, that net replenishment of nerve terminal glutamate and GABA occurs directly via trafficking of astroglial glutamine. In the nerve terminals, the turnover kinetics of glutamate (but not of GABA) was slower compared to the cortex, possibly reflecting selective effects of anesthesia on activity-dependent glucose use, which might be more pronounced in the terminals. There is also a higher dilution of glutamate in the nerve terminals, consistent with glutamine trafficking occurring there.
Materials and Methods

Animal Preparation
All animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and protocols were approved by the Yale Animal Care and Use Committee. Male Wistar rats (160-180 g), were fasted overnight, anesthetized with 2-3% halothane in 30% O 2 /67-68% N 2 O, tracheotomized, and ventilated. The left femoral artery was cannulated for continuous monitoring of arterial blood pressure and intermittent sampling of blood for the measurement of glucose and gases. The left femoral vein was cannulated for the infusion of [1,6- 13 C 2 ]glucose or [2-13 C]acetate. Body temperature was maintained near 37 °C using a heating pad connected to a temperature-regulated circulating water bath. Following surgery, the halothane flow was reduced to ~1% to maintain blood pressure in the normal range. ) and 120 min (8.00 mmol kg −1 ) in rats maintained under halothane anesthesia using an infusion rate schedule [19] that raises plasma glucose rapidly (<1 min) and maintains a nearly constant level and enrichment thereafter. The concentration of the infused 13 C-glucose was determined for each animal according to body weight (3.75 mol L −1 kg −1 ). Data from animals infused for 8 min (n = 6) and 60 min (n = 3 of 5) were taken from a previous study [48] in which animals also received a small amount of 2-fluoro-2-deoxyglucose with the [ ) for 20 min using a rate schedule described previously [24] . At the end of the respective infusions, rats were decapitated and their brains removed for cortical tissue sampling and isolation of nerve terminals.
Isolation of Nerve Terminals
The nerve terminals (NT) were isolated from the forebrain (entire brain excluding cerebellum and olfactory bulb) using the differential and gradient centrifugation method of Lai and Clark [61] . Briefly, rats were decapitated at the appropriate times, brains were quickly removed and the weight recorded using pre-weighed beakers containing ice-cold isolation medium (0.32 M sucrose, 10 mM HEPES, and 1 mM EDTA at pH 7.4). A small quantity (~40 mg) of intact neocortical tissue (fronto-parietal cortex, Ctx) was dissected and frozen for subsequent extraction and analysis. The forebrain tissue was chopped into small pieces using dissection scissors and allowed to settle briefly before decanting the surrounding fluid to remove residual blood. Fresh ice-cold isolation medium was then added to the tissue (10:1 vol/wt) in a large Kontes glass homogenizer, and the tissue was carefully homogenized by several directed passes using the A and B pestles. A fraction (10%) of the resulting homogenate (Hom) was retained and frozen for subsequent extraction and analysis. The remaining homogenate (90%) was centrifuged at 1300×g for 3 min, and supernatants were collected. The resulting pellets were re-suspended in 10 ml of the isolation medium, re-homogenized and then centrifuged at 1300×g for 3 min. The supernatants were pooled and centrifuged at 17,000×g for 10 min to obtain the crude mitochondrial fraction. The resulting pellet was re-suspended in 15 ml of isolation medium and carefully layered onto a Ficoll gradient (11 mL of 7.5% wt/vol over 11 mL of 10% wt/vol), followed by centrifugation (in a Beckman SW28 rotor, 99,000×g, 45 min). The nerve terminals sedimented at the interface between the 7.5% and the 10% Ficoll gradient. They were collected using a transfer pipette, washed twice with NaCl (150 mM) to remove residual sucrose, and pelleted by centrifugation (17,000×g, 10 min). The nerve terminals were assumed to be relatively pure based on previous findings of low activity of the astrocytic markers, glutamine synthetase and GFAP, and their characteristic appearance by electron microscopy where the same isolation method was employed [48] .
Extraction of Metabolites from Forebrain Nerve Terminals, Forebrain Homogenate and Fronto-Parietal Cortex and Preparation of Supernatants for NMR Spectroscopy
Nerve terminal (NT) pellets were homogenized with icecold ethanol (1:6 vol/vol; ethanol 60%: deionized water 40%) in an Eppendorf tube with plastic pestle until no visible pieces remained. [2- 13 C]glycine (10 mM, 25 μL) was added as an internal concentration reference to correct for potential losses during the extraction procedure. The homogenate was frozen and thawed three times to ensure complete cell lysis, and clarified by centrifugation (20,000×g).
The frozen forebrain homogenate (Hom) was mixed with ice-cold ethanol (1:6 vol/vol; ethanol 60%: deionized water 40%) in an ice-cold glass homogenizer, frozen and thawed three times to ensure complete cell lysis, and clarified by centrifugation (20,000×g). The supernatant, which contained the relevant amino acids and high levels of sucrose, was applied over an anion exchange column (AG 1-X8) for isolation of the amino acids. Neutral amino acids (GABA and glutamine) and sucrose were eluted using deionized water, whereas glutamate and aspartate were eluted using 2M acetic acid. The glutamate fraction was lyophilized and processed for NMR spectroscopy as described below. Since the neutral fraction (containing GABA and glutamine) contained a very high concentration of sucrose with extensive degree of overlapping NMR signals, GABA and glutamine were not measured in the homogenate (Hom).
The frozen fronto-parietal cortex (40-50 mg) was extracted by pulverizing tissue with 0.1M HCl:MeOH (2:1 vol/wt) in a dry-ice/ethanol bath, then transferred to a wetice bath wherein the tissue was homogenized with ice-cold ethanol followed by centrifugation and prepared for NMR as described next.
The supernatants (metabolite fraction) of nerve terminals (NT), homogenates (Hom) and cortex (Ctx) were lyophilized, and re-suspended in 500 µL of a phosphate-buffered (100 mM, pH 7) deuterium oxide (Cambridge Isotopes, Andover, MA) solution containing 3-trimethylsilyl [2,2,3,3-D 4 ]-propionate (0.25 mM), as chemical shift reference.
NMR Spectroscopy and Analysis of Plasma and Brain Extracts
All NMR spectra were acquired at 11.7T on a Bruker AVANCE NMR spectrometer (Bruker Instruments, Billerica, MA). Blood plasma was mixed with D 2 O and large macromolecules were removed by passage of the samples through a centrifugal filter (10 kDa cut off, Nanosep, Gelman Laboratory, MN). The percentage 13 C enrichment of plasma glucose-C1α was determined from the fully relaxed 1 H NMR spectrum by dividing the intensities of the two 13 C satellites by the total ( 12 C+ 13 C) intensity centered at 5.23 ppm.
Fully relaxed 1 H-[ 13 C]-NMR spectra of neural preparations were acquired as described earlier [48, 62] . Metabolite concentrations were determined relative to the added [2- 13 C]glycine (reference standard) in the 13 C difference spectrum. Isotopic 13 C enrichment refers to the ratio of metabolite resonance area in the difference spectrum ( 13 C only) to total area in the non-edited spectrum ( 12 C+ 13 C), minus 1.1% natural abundance.
Determination of Amino Acid Turnover Parameters
Rate constants (k) of 13 C turnover of amino acids were estimated by non-linear least-squares fitting of an exponential function to the time course data using GraphPad Prism software, version 6 (GraphPad Software, Inc., La Jolla, CA). During the fitting both k (τ 1/2 = ln2/k) and steady state 13 C labeling were iterated to achieve the best fit of the exponential function to the experimental data.
Determination of Metabolic Fluxes for Cortical Tissue Using Metabolic Modeling
Metabolic fluxes were determined by fitting the threecompartment metabolic model (glutamatergic neuron, GABAergic neuron and astroglia) to the time courses of 13 C enrichments of Asp C3 , GABA C2 , GABA C3 , Glu C4 , Glu C3 , and Gln C4 generated ex vivo after [1,6-13 C 2 ]glucose infusion [24] . The reliability of the flux estimates was improved by using fixed values of the ratios, V cyc(Glu−Gln) /V TCA(Glu) (0.45) and V cyc(GABA−Gln) / V TCA(GABA) (0.63) as determined by Patel et al. [24] . These values were determined in fronto-parietal cortex of halothane-anesthetized Sprague-Dawley rats for isotopic steady state following an [2- 13 C]acetate infusion (2 h) (see Supplement Material in [24] for a derivation of the equations used to calculate the respective V cyc / V TCA ratios). Thus, the ratio values reflect the same conditions of anesthesia and brain region measured in the present study. In brief, mass and 13 C isotope flows from [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose into neuronal and astroglial metabolite pools were written as coupled differential equations within the CWave software package. The differential equations were solved numerically using a 1st/2nd order Runge-Kutta method, and curves were fitted using the Levenburg-Marquardt algorithm.
Statistics
Parameter estimates are reported as mean ± standard deviation (SD). Statistical significance levels (P values) for comparisons of between-group differences in turnover rate constants (k) were estimated from their uncertainty distributions based on 1000 Monte-Carlo simulations of each data set using CWave software. The P values were multiplied by 3 to adjust for three comparisons (nerve terminals, homogenate and cortex) and reported as P adj .
Statistical significance of between-group differences in 13 C enrichment at the different infusion times was assessed by one-way ANOVA with repeated measures and Tukey's test using OriginPro 2016 software (OriginLab, Northampton, MA, USA). The uncertainties in the absolute fluxes obtained by fitting the metabolic model to the cortex time course data were assessed by MonteCarlo simulation with 1000 iterations. P values <0.05 were considered statistically significant.
Results
C Labeling of Amino Acid in Nerve Terminals and Brain Tissue Extracts
Carbon-13 isotopic enrichments in extracts of forebrain nerve terminals, forebrain homogenate and a piece of fronto-parietal cortical tissue were determined from the 1 H-[
13 C]-NMR spectra. Figure 1 shows an example of the 13 C-labeled methylene spectral region of the extracted nerve terminals and parietal cortex of a single animal following an infusion of [1,6-13 C 2 ]glucose for 120 min. Prominent 13 C labeling is seen (in order of decreasing intensity) in Glu C4 , Glu C3 , GABA C2 , GABA C3, and Asp C3 . Amino acid labeling patterns in nerve terminals and cortical tissue were qualitatively similar, with exception of Gln C4 present in cortical tissue, but absent from the nerve terminals. The relative concentration of GABA to glutamate was considerably higher in the nerve terminal fraction, which could reflect a higher recovery of GABAergic nerve terminals or relatively more synapses in the midbrain, although autolytic production from glutamate is also a possibility. Figure 2 depicts the time courses of 13 C labeling (expressed as percentage 13 C enrichment) of Glu C4 , Glu C3 , GABA C2 and Asp C3 in forebrain nerve terminals and homogenate (excluding GABA), and fronto-parietal cortex (including Gln C4 ) from a series of timed infusions of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ] glucose. The 13 C enrichment levels in the amino acids rose progressively with time for all measured carbon positions and within the respective preparations in the order Glu C4 > GABA C2 > Gln C4 (cortex) ≈ Asp C3 > Glu C3 with asymptotic approach to approximately constant (steadystate) values for Glu C4 , GABA C2 and Gln C4 .
Isotopic Turnover of Amino Acids in Nerve Terminals and Tissues
The Glu C4 enrichment was significantly lower in forebrain nerve terminals compared to homogenate or cortex for all infusion times (P < 0.02 to P < 0.0001; Fig. 2 , table inset; Supplementary Material, Table S1 ). There was a trend toward lower Glu C4 enrichments in homogenate compared to cortex for early time points, but the difference was significant only for 60 min (P < 0.05) and for the combined (60 + 120 min) (P < 0.01) data. The Glu C3 enrichment in nerve terminals was significantly lower than in cortex (P < 0.05) but not in homogenate for the 8 min time point, while no other time points showed significant differences. In nerve terminals, Asp C3 enrichment at 60 min differed significantly from homogenate (P < 0.05) and cortex (P < 0.01), although data scatter was particularly high at this time point. The GABA C2 enrichments in nerve terminals and cortex were similar for all time points although slightly lower enrichment (P < 0.05) was seen in the nerve terminals for the combined (60 min plus 120 min) data.
For the nerve terminals, homogenate and cortex the turnover rate constants (and corresponding half-times, τ 1/2 ) for the labeling of Glu C4 , GABA C2 , Glu C3 , Asp C3 and Gln C4 (cortex only) were estimated by nonlinear least-squares fitting to a single exponential function (Fig. 2) . A summary of analysis results appears in Table 1 . With the exception of Asp C3 (r 2 = 0.67), a single exponential fit the data well with correlation coefficients of 0.89-0.97. The rate constant for Glu C4 turnover was significantly less for nerve terminals compared to homogenate (P adj = 0.021) or cortex (P adj < 0.001), corresponding to turnover times being longest in nerve terminals (21.8 min) compared to homogenate 13 C enrichment of amino acids in cerebral cortex (Ctx), homogenate (Hom) and nerve terminals (NT) in anesthetized rats receiving timed intravenous infusion of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-glucose. Lines reflect best fit of a single exponential function to each data set consisting of 13-15 animals. Uncertainty distributions of the fitted rate constants (insets) for each turnover curve were assessed by Monte-Carlo simulation with 1000 iterations using the CWave software. P adj -values were determined from the distributions of the rate constants (see Table 1 ). Statistical significance of between-group differences in the 13 C enrichments was assessed by one-way ANOVA with repeated measures and Tukey's test. The 120 min time point consisted of too few animals (N = 2) for statistical analysis; this data was combined with the 60 min data (60 + 120 min). The 13 C enrichment data from animals infused for 8 min and 60 min were taken from Patel et al. [48] or cortex (12.4-14.2 min). The difference in the rate constant between homogenate and cortex was not significant (P adj > 0.6). For GABA C2 , the difference in turnover rate constant and half-times between terminals and cortex appeared slightly less marked than for Glu C4 , which did not reach statistical significance (P = 0.07). Corresponding information for GABA (and glutamine) in the homogenate was not available, as these amino acids co-eluted with the highly concentrated sucrose in the neutral fraction, overwhelming their NMR signals and precluding their measurement. Differences in rate constants for Asp C3 turnover were not significant (P adj > 0.8). Averaging across homogenate and cortex, turnover times were longer for Asp C3 (~2.2x) and Glu C3 (~3.5x) compared to Glu C4 , consistent with the expected sequential delay in labeling of these carbon atom positions within the TCA cycle (Asp C3 is labeled in the 1st Table 1 13 C isotopic turnover kinetics and quasi-steady state enrichments of amino acids in forebrain nerve terminals and homogenate and cortical tissue from anesthetized rats infused intravenously with [1, [6] [7] [8] [9] [10] [11] [12] [13] 
Turnover parameters [mean (SE)] were estimated by non-linear least squares analysis of amino acid 13 C percentage enrichments vs. time data to a single exponential function using 12-15 rats per data set. Turnover half-times (τ 1/2 ) were calculated as τ 1/2 = ln(2)/k P values for rate constant (k) group comparisons were estimated from the probability distributions calculated by Monte-Carlo analysis (see Fig. 2 ) and multiplied by 3 to adjust for comparisons between the three groups (NT, Hom, Ctx). P values for E SS′ group comparisons were determined by one-way ANOVA with repeated measures and Tukey's test to adjust for multiple comparisons. *P < 0.05, **P < 0.001 and ***P < 0.0001 for comparisons of NT vs. Hom; Glu C4 glutamate-C4, Glu C3 glutamate-C3, GABA C2 γ-aminobutyrate-C2, Gln C4 glutamine-C4, Asp C3 aspartate-C3, NT nerve terminals, Hom homogenate, Ctx cortex, NA not available a E ss′ is the apparent steady-state 13 C percentage enrichment averaged over 60 and 120 min (n = 5-7). Amino acid 13 C enrichments reflect excess above natural (1.1%) abundance, and were normalized by the respective animal's plasma glucose-C1 enrichment before computing group means. Equivalency of plasma glucose-C1 and -C6 13 C enrichment was assumed b C tot is the respective total ( 12 C + 13 C) amino acid (AA) concentration (mean (SD)) as measured for cerebral cortex or estimated relative to N-acetylaspartate (NAA) in the nerve terminals c In nerve terminals (NAA) was assumed to be equal to the average cortical concentration (11.32 ± 2.17 μmol g −1 ) multiplied by the forebrain-tocortex ratio for NAA (f fb/ctx NAA = 0.93) determined from Wang et al. [63] d In homogenate, C tot was calculated from the average cortical concentrations of glutamate (13.32 ± 1.22 μmol g −1 ) and GABA (2.50 ± 0.29 μmol g −1 ) multiplied by the respective forebrain-to-cortex ratio for glutamate (f fb/ctx Glu = 0.93) or GABA (f fb/ctx Gaba = 1.29) determined from Wang et al. [63] . NAA, which is present only in neurons, was assumed to be uniformly distributed in neuronal cytoplasm (see [48] for a discussion) e In cortex, the respective amino acid concentrations (C tot ) were measured in the extract f Flux was calculated as the product, k × C tot . The flux value for homogenate was determined using amino acid concentrations in cerebral cortex, and is considered an upper limit and 2nd turns, whereas Glu C3 is labeled in the 2nd turn), and the effect of label scrambling at fumarate C2 and C3.
Estimation of Glutamate and GABA Turnover Fluxes in Nerve Terminals and Tissues
The rate constants ( ) and f fb/ctx NAA (0.93) is the ratio of NAA in forebrain over fronto-parietal cortex calculated from brain regional concentrations and tissue weights reported in Table 1 and Supplement Table 2S , respectively, from [63] . For cortex (ctx), the Glu C4 and GABA C2 turnover fluxes were calculated as: ) concentrations measured in cortex, and 29) are the respective ratios of forebrain over fronto-parietal cortex for glutamate and GABA calculated from Wang et al. [63] .
Computing the turnover fluxes using these expressions and parameter estimates for Glu C4 gave 0.33 ± 0.09 μmol g (nerve terminals) and 0.12 ± 0.02 μmol g −1 min −1 (cortex).
Source of Steady-State Enrichment Dilution in Nerve Terminal Glutamate
To address whether inflow of an unlabeled substrate into the nerve terminals (e.g., glutamine) might explain the lower steady-state 13 C enrichments, we compared the 13 [64, 65] , leading to labeling of Gln C4 by astrocyte specific glutamine synthetase [66] . Following Gln C4 release from astrocytes and uptake into neurons, glutaminase action converts Gln C4 to Glu C4 . Therefore, the enrichment of Gln C4 will exceed Glu C4 following an infusion of [2- 13 C]acetate, whereas the reverse is observed with [1,6-13 C 2 ]glucose as substrate. The 13 C labeling of Glu C4 in nerve terminals and cerebral cortex, and of Gln C4 in cerebral cortex following short-time infusions of [1,6-13 C 2 ] glucose or [2- 13 C]acetate is shown in Fig. 3 . The 13 C labeling of Glu C4 from [1,6-13 C 2 ]glucose was significantly less in nerve terminals compared to cerebral cortex (P = 0.001). In contrast to the labeling from glucose, Glu C4 percentage enrichment from [2- 13 C]acetate in the nerve terminals was similar to cerebral cortex, although too few acetate-infused rats were studied to assess statistical significance. When expressed as the ratio, 13 C labeling from acetate relative to glucose was twice as large in the nerve terminals (0.28) than in cerebral cortex (0.13). Together with the findings of a higher steady-state dilution in Glu C4 from 13 C-labeled glucose (Table 1) , the higher acetate-to-glucose enrichment ratio in nerve terminals strongly suggests that glutamate repletion from glutamine is more concentrated in the nerve terminals.
Estimation of Metabolic Fluxes in Cortex with Metabolic Modeling
Anesthetics depress metabolism in a dose and time dependent manner. To interpret differences in Glu C4 and GABA C2 turnover between nerve terminals and whole tissue, and compare it to fluxes determined in anesthetized and awake rats in previous 13 C MRS studies, absolute fluxes were determined for fronto-parietal cortex by metabolic mathematical modeling. The three-compartment metabolic model described in Patel et al. [24] and Methods was fitted to the enrichment time courses of blood plasma glucose C1,6 and fronto-parietal cortex Glu C4,C3 , GABA C2,C3 , Gln C4 and Asp C3 (Fig. 4) , providing estimates of rates of the TCA cycles, glutamate/GABA-glutamine cycles, glutamine synthesis, and related dilutions in neuronal (glutamatergic and GABAergic) and astroglial compartments ( Table 2 ). The best fit of the metabolic model yielded estimates of the TCA cycle rate for glutamatergic neurons (0.68 ± 0.07 μmol g −1 min , respectively. Certain parameters were constrained as fixed values in the model, including the ratios, V cyc /V TCA(N) and pyruvate carboxylase-to-glutamine synthesis rates, V pc /V Gln , and the α-ketoglutarate-glutamate exchange rate in astrocytes, V x(A) . We evaluated the sensitivity of the estimated fluxes to the fixed parameters, systematically altering their values above or below the nominal value and recalculating the values of the fluxes, which we then expressed as the percentage change from their respective nominal values (Supplementary Material, Table S2 ). The largest effect of a change (±25% of nominal) in V cyc /V TCA(N) was seen in the dilution fluxes in glutamatergic neurons and astrocytes (V dil(Glu) , −28 to 34%; V dil(A) , 66 to −78%) and glial TCA cycle flux (V TCA(A) , 17 to −20%), whereas effects on neuronal TCA cycle fluxes (V TCA(Glu) , −5 to 6%; V TCA(GABA) , ±7%;), glutamine synthesis (V gln , ±0.7%), or glutamine dilution (V dil(Gln) , ±0.7%) tended to be small. Altering the value of the ratio, V pc /V Gln , by ±25% above or below the nominal value of 0.2, produced the largest effects on V dil(A) (18% to −17%) and V TCA(A) (±10%), whereas effects on all other fluxes were less than ±6%. For changes in V x(A) from 10 to 0.1 times V TCA(A) , the effects on estimated fluxes were small (less than ±4%).
Discussion
This study determined the isotopic turnover of glutamate and related amino acids in forebrain nerve terminals and whole tissue fractions (forebrain homogenate and frontoparietal cortex) from anesthetized rats infused intravenously with 13 C-labeled glucose or acetate. We found that the rate of Glu C4 turnover-a reflection of TCA cycle activity-was slower in nerve terminals than in brain homogenate or cortex, whereas their rates of GABA C2 turnover were similar. Furthermore, we found that the steady-state 13 C enrichment, which reflects the sum of all substrate inflows to Glu C4 (both directly and indirectly through acetyl-CoA) was lower in nerve terminals compared to those in the Fig. 4 Fit of the metabolic model to the ex vivo time courses of amino acid labeling from [1,6-13 C 2 ]glucose for extracts of frontoparietal cortex (Ctx). The line represents the best fit of a threecompartment (glutamatergic and GABAergic neurons, astrocytes) metabolic model to glutamate-C4 and -C3, GABA-C2 and -C3, glutamine-C4 and aspartate-C3 enrichment time courses, providing flux estimates for these neural cell populations in cerebral cortex (Table 2) tissue fractions-implying a dilution by non-isotopically labeled precursor substrate(s)-although this difference in enrichment (dilution) was less for GABA C2 . Employing [2- 13 C]acetate, an astroglial substrate, we found the lower steady-state enrichment of Glu C4 from 13 C-glucose in the terminals is consistent with higher relative inflow of an unlabeled (or less C4 enriched) substrate, most likely glutamine [7, 26, [67] [68] [69] [70] [71] .
The finding of a lower glutamate 13 C turnover rate in nerve terminals compared to that in the whole tissue was surprising, particularly as the metabolic rate at axon terminals/dendrites is believed to be the highest within a neuron based on studies using 2-deoxyglucose autoradiography in awake rats [72, 73] . This result may partly reflect the terminals being harvested from the whole forebrain, which includes many subcortical regions with metabolic rates lower than those seen in the cerebral cortex [38, 63, 74] . Indeed higher GABA/glutamate ratio was seen in the terminals (47%) compared to the cerebral cortex (19%), suggesting a somewhat different neuronal composition. However, the rate constant for Glu C4 turnover for forebrain homogenate, from which the nerve terminals were derived, was not significantly different from cortex (P adj > 0.6), indicating that other factors are more likely to explain the lower turnover rate observed. In our study, animals were anesthetized with halothane throughout the 13 C-glucose infusion and euthanasia, which would reduce cerebral metabolic fluxes relative to the awake state [74] [75] [76] [77] . The TCA cycle and glutamate-glutamine cycle rates in glutamatergic neurons determined for the cortex by modeling of 0.68 and 0.31 μmol g −1 min −1 (Table 2) , were ~57-60% and ~54-69% of the corresponding rates (0.45-0.57 and 1.13-1.19 μmol g −1 min −1
) determined in awake rats by Oz et al. [25] . Anesthesia alters activity-dependent glucose utilization associated with neural activity and neurotransmission [74, 78] . Therefore, halothane anesthesia may have had a greater effect in suppressing glucose oxidation in synaptic terminals/dendrites compared to the neuronal soma, effectively reducing 13 C enrichment and fluxes in nerve terminals relative to neuronal metabolic flux in the tissue as a whole. This can be seen quantitatively [27, 29] by considering the relationship between neurotransmitter glutamate-glutamine cycling and neuronal TCA cycle flux determined over a large range of neural activity (deep anesthesia to awake state) and described by the equation, V TCA(n) = 1.80V cyc + 0.19 [49] . This relation provides an estimate of the fraction of total neuronal TCA cycle flux (presynaptic terminals and dendrites, axons and soma) coupled to glutamate-glutamine cycling through the nerve terminals. For the anesthetized rats in our study, the fraction of glutamatergic TCA cycle flux associated with activitydependent glutamate-glutamine cycling above the isoelectric (basal function) rate of 0.19 μmol g −1 min −1 represents ~72% (=100 × (0.68-0.19)/0.68) of the overall glutamatergic TCA cycle flux (Table 2) . In awake rats, this fraction would be larger, ~83% (=100 × (1.15-0.19)/1.15) assuming the same constant value of the basal rate. If the basal (non-activity dependent) flux is higher, as suggested by Du et al. [79] , then the fraction of TCA cycle flux contributed by neurons (and their terminals) in response to neural activity would be correspondingly smaller. The findings that glutamate turnover flux in the nerve terminals was ~50% lower than homogenate or cortex is in-line with this interpretation.
The increased label dilution in Glu C4 in the nerve terminals compared to whole tissue homogenate or cerebral cortex was a significant finding. Differences in metabolic activity between regions or within cells (e.g., soma vs. axon terminals) contribute to the rate of 13 C turnover but not the steady-state enrichment, which reflects the sum of all the substrates (labeled and unlabeled) feeding the TCA cycles and glutamate pools. Aspartate-C3 also showed a high degree of 13 C label dilution in the terminals, similar to Glu C4, implying greater diluting inflow in this compartment. We found no evidence of an unlabeled metabolite(s) overlapping glutamate-H4 and aspartate-H3 to explain the lower enrichment.
The magnitude of the Glu C4 dilution seen in frontoparietal cortex of 36% (=100−64%; Table 1 ) is well within the range of 27-39% observed in cerebral cortex of rats infused with [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose [39, 62] . Metabolic pathways that could potentially contribute to the isotopic label dilution in Glu C4 include blood-to-brain exchange with unlabeled lactate/pyruvate in blood [33], the pentose phosphate pathway (PPP) [80] [81] [82] [83] and (or) dilution in Gln C4 transported to neurons via glutamineto-glutamate cycling [28, 34, 70, 71] . Blood-to-brain lactate exchange is unlikely to be a major source of the Glu C4 dilution based on findings by Dienel et al. [83] of negligible exchange of brain lactate/pyruvate with blood following a brief pulse of 14 C-lactate. It is possible to estimate an upper limit of this dilution using the data reported in Herzog et al. [84] . In this study, [3- 13 C] lactate was infused intravenously into anesthetized rats, raising blood lactate to ~3 mM (from ~1 mM basal) and ~35% 13 C enrichment. The infusion resulted in a timedependent rise in Glu C4 enrichment to ~4% at isotopic steady state. Insulin was co-infused with lactate to suppress gluconeogenesis and 13 C label scrambling into glucose, ensuring that brain Glu C4 labeling arose directly from metabolism of 13 C-lactate. When normalized by the blood lactate enrichment (to 100%) and scaled downward to reflect physiological blood lactate levels (~1 mM), the predicted steady state Glu C4 enrichment (equivalent to dilution in the case of unlabeled blood lactate) would be ~3.8% (=(4%/35%) × (1 mM/3 mM)), which is ~1/10 of the observed dilution. As noted above, [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose metabolized through the PPP, which results in the loss of C1 label as 13 CO 2 , reduces the enrichment at pyruvate-C3 relative to that produced solely by glycolysis. In neurons, pyruvate-C3 dilution arising through the PPP would not be distinguished in our experiment from the effects of blood-to-brain exchange of unlabeled lactate, whereas in the astrocytes either dilution would appear in the Gln C4 dilution. Estimates of PPP flux in brain range from 2 to 4% of total glucose metabolism [80] [81] [82] , providing at most ~1-2% dilution of Glu C4 (50% loss of 13 C label due to metabolism of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose through the PPP). Thus, dilutions from blood lactate exchange and PPP together could account potentially for ~5-6% dilution of Glu C4 , or 14-17% of the total dilution observed. In modeling of the cortex enrichment time courses (Fig. 4) , dilutions into α-ketoglutarate via lactate/pyruvate (V dil ) and into glutamine (V dil(Gln) ) were included as iterated fluxes. The relative contributions in neurons of the lactate/pyruvate and glutamine dilutions to overall dilution in Glu C4 can be approximated as the ratios, V dil / (V TCA +V cyc ) and ((V dil(Gln) /V Gln ) × V cyc )/(V TCA +V cyc ). Using values from Table 2 for glutamatergic neurons, estimates of the lactate/pyruvate and glutamine dilution fractions would be ~13% and ~25% of overall dilution, respectively. Thus, V dil estimated by metabolic modeling for the cortex appears consistent with an estimate of combined lactate/pyruvate exchange and PPP. If V dil and V TCA scale proportionately in cortex and nerve terminals, the larger Glu C4 dilution in the nerve terminals of ~51% (=100−48.5%; Table 1 ) can be attributed to increased flow from glutamine via glutamate-glutamine cycling.
Other sources of glutamate dilution in nerve terminals could come from glutamate trapped in vesicles that recycle very slowly (e.g., the reserve pool) or presynaptic reuptake of less-enriched glutamate from extracellular fluid. Estimates of the fraction of recycling vesicles in relation to total vesicles in nerve terminals of CNS synapses during physiological activity range from lows of 5-20% [85, 86] to most of all vesicles present [87] . Direct measurements of the 13 C enrichment of the vesicular glutamate in the nerve terminals will be required to resolve this issue. Pre-synaptic reuptake of glutamate into neurons has been shown [88] , and nerve terminals express GLT-1 glutamate transporter [89] . Studies of mice with knockout of neuronal GLT-1 suggest that reuptake could account for up to 40% of synaptic clearance [89] . Considering the small extracellular diffusion volume of the synaptic cleft active zone (~44 × 10 −3 μm 3 or <50 pL; [90] ), the rapid turnover of this pool (e.g., cleft glutamate clearance in <20 msec at Calyx synapses [87] ), and high glutamate-glutamine flux [29] , the 13 C enrichment of cleft glutamate would be expected to follow closely the enrichment of released glutamate. Because the glutamate returning to the terminal by reuptake would have the same enrichment as vesicular glutamate, it is not likely to be the source of Glu C4 dilution.
We note that any label dilution in Glu C4 originating in neurons could not produce a level of dilution in Gln C4 exceeding that of Glu C4 at isotopic steady state, in general accord with the precursor-product relationship. The greater dilution seen in Gln C4 over that of Glu C4 at isotopic steady state (Table 1) [71] is related to metabolism of unlabeled substrates in astrocytes. This is seen experimentally in studies where [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glucose is co-infused with unlabeled acetate (an astroglial precursor), resulting in significantly lower Glu C4 and Gln C4 steady state enrichments [24] compared to [1,6- 13 C]glucose infused alone [39] . The difference in labeling between Glu C4 and Gln C4 produced by the dilution in astrocytes was shown to be critically important for the determination and reliability of the glutamate/ GABA-glutamine cycling rate in the 13 C MRS experiment [71] .
The replenishment of glutamate in neurons by less enriched astroglial precursors during synaptic activity might be more prominent in the terminals [67] . The heightened enrichment of Glu C4 from 13 C-labeled acetate relative to glucose in nerve terminals, as compared to cerebral cortex, is consistent with an astroglial substrate(s), e.g. glutamine, as the likely source of isotopic dilution. In addition to glutamine, however, nerve terminals in vitro can also take up α-ketoglutarate, suggesting the potential for astroglial TCA cycle intermediates as precursors of neurotransmitter glutamate [56, 91] , which would also possess a similar or higher dilution than glutamine. Glutamate formation from glutamine, however, is not limited to nerve terminals because mitochondrial phosphate-activated glutaminase (PAG) is present throughout the neuron [92] , ensuring sufficient capacity for conversion of glutamine to glutamate. PAG inhibition by 6-diazo-5-oxo-L-norleucine leads to loss of glutamate in synaptosomes [93] and cell bodies of pyramidal (glutamatergic) neurons visualized in situ by immunostaining [94] . On the other hand, the concentrated release and regeneration of glutamate from glutamine in nerve terminals could lead to the higher constant dilution observed in this compartment, particularly if inducible glutamine transport and conversion of glutamine to glutamate is faster in the terminals during neural activity in vivo (e.g., see [95] ).
In contrast to the lower average steady state enrichment (60 + 120 min) of Glu C4 in the nerve terminals, which differed from homogenate or cerebral cortex by ~18-24%, the difference in enrichment from cortex was less for GABA C2 (~13%) ( Table 1) . This is not due to the absence of a diluting inflow in GABAergic terminals because GABA C2 was less enriched than Glu C4 at steady-state (36.4% vs. 48.5%), indicating that GABA synthesis also involves a significant dilutional inflow. The smaller enrichment difference in GABA C2 suggests that non-isotopic inflow (dilution) in glutamate precursors might occur more widely throughout the GABAergic neuron. Alternatively, the smaller physical size (and diffusion distance) of the majority of GABAergic neurons relative to glutamatergic neurons (e.g., pyramidal cells) would be anticipated to lead to faster mixing between nerve terminal and soma glutamate pools. Moreover, pioneering early studies [1, 2, 96] found that the glutamate precursor pool of GABA behaved kinetically as a physically compartmented smaller pool within the so-called 'large pool glutamate', both of which are present in the nerve terminals. Thus, the similar enrichment seen for GABA C2 in cortex and nerve terminals, and for Gln C4 in cortex, along with the suspected low concentration of the glutamate precursor pool, suggests that in GABAergic neurons intracellular mixing of glutamate precursors used in GABA synthesis is more complete than in glutamatergic neurons. Further studies will be needed to confirm this possible mechanism.
The steady-state enrichment in GABA C2 of 36-42% in terminals and cortex was less than the theoretical enrichment of 52% expected from the infused 13 C-labeled glucose acting as sole substrate, thus indicating that GABA synthesis also included a dilution flux component. This is consistent with previous descriptions of the glutamine dilution [70, 71] and glutamine's contribution to GABA synthesis [5, 7, 14, 68, 69, [97] [98] [99] [100] . Unlike synaptic release of glutamate, which is cleared mainly by astroglial glutamate transporters, GABA is extensively recycled after synaptic release by reuptake into GABAergic terminals via GABA transporters, as well as by astroglial uptake [4, 101, 102] . Because much of the basal GABA synthesis is mediated by GAD 67 [103] [104] [105] , which is expressed in the cytoplasm of cell bodies and terminals of GABAergic neurons, the reuptake/release of GABA by reversible GABA transporters might contribute to faster and more efficient mixing of GABA (labeled and unlabeled) between subcellular compartments.
In a previous study by Patel et al. [48] , we reported that the rates of glucose phosphorylation in forebrain nerve terminals and tissue homogenate isolated ex vivo from halothane anesthetized rats infused with 2-fluorodeoxyglucose (FDG) were the same at rest and during seizures. The finding in the present study that the flux of glucose into nerve terminals was half that seen in homogenate or frontoparietal cortex (Table 1) suggests that under our study conditions, nerve terminals are more glycolytic, producing pyruvate in excess of oxidative needs. The question of whether neurons consume lactate provided by astrocytes [45, 106] or directly produce and release it [107] is unresolved. It should be possible in future studies to employ the nerve terminal preparation with prior co-infusions of FDG and 13 C-glucose to address this issue and others (e.g., the contribution of the PPP flux).
Limitations of the Study
Methodological constraints limited our amino acid assessments in homogenates to glutamate and aspartate. In contrast to the extracts of fronto-parietal cortex, which did not contain the sucrose used to prepare the homogenates, or nerve terminals where sucrose was removed in the final step of their isolation, homogenate extracts contained high levels of sucrose. We used ion-exchange chromatography to separate sucrose from glutamate and aspartate, allowing fractional enrichments and their turnover to be determined, although no attempt was made to separate GABA and glutamine from co-eluted sucrose.
The animals in our study were anesthetized which may have affected the relationship between the measured fluxes as compared to the awake state. Anesthesia depresses glucose metabolism and glutamate-glutamine cycling proportionately above the isoelectric condition [27, 39, 46] . While this relationship has been determined for cerebral cortex, it has not been assessed for the nerve terminals. As discussed in Methods, anesthesia is assumed to alter metabolic rate (early times in the enrichment curve) but not the steady state enrichment, which reflects the inflows of all substrates ( 13 C labeled and unlableled) flowing into the glutamate pool. This assumes that the relative utilization of 13 C-labeled and unlabeled substrates in brain tissue and nerve terminals are not affected by anesthesia. In awake animals, we would expect Glu C4 enrichment to be higher in synaptic terminals (at early times during the 13 C-glucose infusion) compared to anesthetized animals, in line with what has been seen in anesthetized and awake rat cortex over a range of metabolic activity. This relationship, however, has not been assessed in nerve terminals and requires validation. The approach we have developed here should be valuable in this regard. Potential effects of anesthesia on the steady state 13 C enrichment are also possible, which could alter the relative label and dilutional flows to glutamate. Of the many studies performed under anesthesia, reported values for the glutamine dilution (as measured by the difference between Glu C4 and Gln C4 over the blood glucose enrichment) appear similar, suggesting activity, per se, does not markedly alter this dilution. Further work is needed, however, to verify this in the nerve terminals under both low and high activity conditions, compartment where the magnitude of the glutamine dilution appears to be much greater.
The calculation of nerve terminal fluxes for glutamate and GABA were made by reference to N-acetylaspartate (NAA), a well-established neuron-specific marker [108] , which we assumed to be constant in concentration 1 3 throughout brain and neuronal cytoplasm. NAA synthesis occurs in mitochondria, and their presence/absence in different parts of a neuron might affect local NAA concentrations, leading to a potentially large source of error in the calculated fluxes. Mitochondria, however, are widely distributed throughout neurons, including the nerve terminals, and undergo continuous movement, as mitochondrial trafficking [109] plays an important role in matching energy supply to energy demand [110] . Nerve terminals prepared as in the current study, contain mitochondria along with numerous synaptic vesicles [48, 61] . The brain concentration of NAA in adult rats under physiologically normal conditions is relatively constant at ~6-8 mM across multiple brain regions [63] . A rough estimate of the diffusion time for NAA to travel a characteristic distance in the cell can be calculated using the Einstein-Smoluchowski relationship, which relates the diffusion coefficient (D, μm 2 ms The in vivo NMR visibility of nerve terminal glutamate and other metabolites is currently unknown. In the present study we examined cell-free extracts where all components were NMR-visible and weighted mainly according to their concentration. To the extent that nerve terminal metabolites are partly or wholly NMR invisible in vivo, the concentration of glutamate and the contribution of the glutamine dilution to glutamate would be underestimated. Future studies using a diffusion-weighted NMR approach could conceivable resolve this issue.
The majority of studies modeling brain amino acid metabolism assumed that metabolic rates and labeling are constant within a given cell type, i.e., glutamatergic neurons, GABAergic neurons or astrocytes. Furthermore, it is assumed that within a neural cell all compartments have the same labeling, which would occur if diffusional mixing between compartments is relatively fast compared to the labeling rate within a compartment (e.g., nerve terminal, dendrite and soma) providing an accurate average rate of cellular metabolism. The present results suggest, however, that mixing between the nerve terminal and other compartments within glutamatergic neurons in vivo may not be fast enough to equalize labeling, at least under the conditions of anesthesia where metabolic rates are much slower. As a consequence of the increased dilution of the nerve terminal glutamate pool, the contribution of this compartment to total cellular glutamate metabolism is likely to be underestimated in studies employing 13 C-labeled glucose. Future studies of nerve terminals isolated from single regions (e.g., from the cortex [100] ) in awake animals should help to resolve this issue.
Conclusions
We have demonstrated that nerve terminals (synaptosomes) isolated ex vivo from rats receiving 13 C-labeled glucose or acetate by intravenous infusion provides unique information on the turnover of glutamate, GABA and other metabolites in the nerve terminal compartment as expressed in vivo. The 13 C isotopic turnover of nerve terminal amino acid pools displayed exponential kinetics, similar to that in whole tissue, thereby facilitating the application of metabolic modeling strategies. We found that Glu C4 turnover in nerve terminals was significantly slower than in whole tissue (forebrain homogenate or cortex), whereas GABA C2 turnover was similar, findings which may be related to the effects of anesthesia and (or) differences in the rates of mixing of these pools with other glutamate containing pools. Nerve terminal glutamate-C4 also displayed a significantly higher dilution inflow coming from an unlabeled substrate. Nerve terminals isolated following infusion of [2- 13 C]acetate, a glial substrate, showed a higher ratio of 13 C labeling in Glu C4 from [2- 13 C]acetate over [1, [6] [7] [8] [9] [10] [11] [12] [13] C]glucose, suggesting that much of the dilution in Glu C4 isotopic enrichment arose from astroglial glutamine. This finding is consistent with the glutamate-glutamine cycle being the main source of repletion for nerve terminal glutamate. Future studies employing nerve terminals isolated from awake animals, and from more anatomically distinct brain regions, will undoubtedly resolve these mechanistic issues. NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem Int 22:19-29 15. Kanamori K, Kondrat RW, Ross BD (2003) 13 C enrichment of extracellular neurotransmitter glutamate in rat brain-combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo. Cell Mol Biol (Noisy-le-grand) 49 
